CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

A Phase 2 Study of VP-16 Ifosfamide and Cisplatin ( VIP ) Combination Chemotherapy Plus Early Concurrent Thoracic Irradiation ( TI ) for Limited Small Cell Lung Cancer

In Sook Woo, Young Suk Park, Young Lee Park, Jung Ae Lee, Myung Jae Park, Ki Suk Jung, In Gyn Hyun, Do Hoon Oh, Hoonsik Bae, Won Suk Kim, Keunchil Park, Hojoong Kim

Cancer Research and Treatment. 1996;28(6):973-981.

VP-16 plus ifosfamide plus cisplatin (VIP) in small cell lung cancer

Alan Sandler

Lung Cancer. 1997;18:154

Link1 Link2

266 A phase II study of VP-16 plus ifosfamide plus cisplatin (VIP) plus concurrent radiation therapy (XRT) for previously untreated limited small cell lung cancer (SCLC): A Hoosier Oncology Group (HOG) trial

A.B. Sandler, R. Ansari, W. Fisher, R. Gonin, R. Levy, L.H. Einhorn

Lung Cancer. 1997;18:70

Link1 Link2

Concurrent platinum (CDDP)-etoposide (VP-16) chemotherapy plus thoracic radiotherapy (TRT) for limited stage small cell lung cancer (SCLC)

Lung Cancer. 1994;10:S337

Link1 Link2

A prospective randomized phase III study in non-small-cell lung cancer comparing cisplatin, ifosfamide, vinbiastine (VIP) versus cisplatin, ifosfamide and etoposide (VIP-16)

Lung Cancer. 1997;16(2-3):279

Link1 Link2

Concurrent cisplatin(CDDP)-etoposide(VP) chemotherapy plus Thoracic Radiotherapy(TRT) for stageIII Small Cell Lung Cancer(SCLC): A Japanese Lung Cancer Chemotherapy Group (JLCCG) study

Lung Cancer. 1991;7:158

Link1 Link2

VP-16, Ifosfamide and cisplatin (VIP) for extensive Small Cell Lung Cancer (SCLC)

Lung Cancer. 1991;7:142

Link1 Link2

VP-16, ifosfamide and cisplatin (VIP) for extensive small cell lung cancer

Lung Cancer. 1995;12(1-2):155

Link1 Link2

Etoposide, ifosfamide and cisplatin (VIP) plus concurrent radiation therapy for previously untreated limited small cell lung cancer (SCLC): a Hoosier Oncology Group (HOG) phase II study

Nasser Hanna, Rafat Ansari, William Fisher, Jianzhao Shen, Sin-Ho Jung, Alan Sandler

Lung Cancer. 2002;35(3):293-297

Link1 Link2

A phase III study of VP16 plus cisplatin (VP) alone or with ifosfamide (VIP) in previously untreated patients (pts) with extensive small cell carcinoma of the lung (SCLC): A hoosier oncology group trial

Lung Cancer. 1994;11:242

Link1 Link2

Phase III trial of cisplatin, vinblastin (VP) vs cisplatin, vinblastin, ifosfamide (VIP) for non-operable non-small lung cancer (NSCLC)

Lung Cancer. 1991;7:107

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.